Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cyclerion Therapeutics Inc (NQ: CYCN )

0.5590 -0.0310 (-5.25%)
Streaming Delayed Price Updated: 11:43 AM EDT, Oct 7, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 152,703
Open 0.5900
Bid (Size) 0.5500 (34)
Ask (Size) 0.5599 (1)
Prev. Close 0.5900
Today's Range 0.5500 - 0.6080
52wk Range 0.4613 - 3.050
Shares Outstanding 43,448,360
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday. 
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga

Performance

YTD
-68.60%
-68.60%
1 Month
-36.03%
-36.03%
3 Month
-16.20%
-16.20%
6 Month
-50.96%
-50.96%
1 Year
-80.59%
-80.59%

More News

Read More
Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction
Via Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies
Via Benzinga
Why Cyclerion Therapeutics Stock Is Getting Hammered
Via Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
Via Benzinga
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
From Cyclerion Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Via Benzinga
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in Patients with Cognitive Impairment Associated with Schizophrenia (CIAS)
From Cyclerion Therapeutics, Inc.
Via Globe NewsWire
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors
From Cyclerion Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
93 Biggest Movers From Yesterday
Via Benzinga
70 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
30 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.